BlackBerry Strengthens Medical Device Software Portfolio with QNX Hypervisor 2.2 for Safety

New Release Helps Companies Deliver Safety-Certified Medical Devices to Market Faster

BlackBerry Limited today announced the release of the QNX® Hypervisor 2.2 for Safety, the latest edition of the company’s safety-certified, real-time embedded hypervisor product, designed to enable the healthcare industry to deliver safe, secure medical devices and applications to market faster.

In addition to being certified to the latest ISO 26262 ASIL D standard for automotive and IEC 61508 SIL3 for electronic systems, the QNX Hypervisor 2.2 for Safety is recognized with the highest functional safety standard for medical device software – IEC 62304 Class C compliance – from the independent auditors at TÜV Rheinland. The new release comes at a time of increased U.S. regulatory scrutiny following the revelation of numerous medical device security vulnerabilities as of late, with the Food and Drug Administration (FDA) releasing draft cybersecurity guidance on medical devices alongside the introduction of two new pieces of legislation – the Protecting and Transforming Cyber Health Care (PATCH) Act and the Healthcare Cybersecurity Act, all of which seek to proactively strengthen cybersecurity healthcare protections and protect lives.

“Medical device manufacturers operate in an environment filled with intense market pressures, stringent safety regulations and concerns about cyberthreats,” said Grant Courville, Vice President, Products and Strategy at BlackBerry QNX. “BlackBerry QNX solutions are used in more than 50 types of medical devices and with the release of the QNX Hypervisor 2.2 for Safety, embedded developers have a software foundation that they can continue to count on which has been specifically designed for safety, security and reliability, enabling them to overcome many challenges at once.”

“At a time when embedded device developers are in a race to adopt the latest technologies to meet feature demands while balancing mixed criticality functions, the safe interoperation of an array of operating systems has never been so important. The latest release of the QNX Hypervisor for Safety brings together pre-certifications across key industry standards including IEC 62304 Class C for medical with additional support needed for high-performance computing. This solution can help deliver responsive user experiences and better time to market while giving organizations confidence that they can achieve their safety goals,” said Chris Rommel, Executive Vice President, IoT & Industrial Technology at VDC Research.

With the QNX Hypervisor 2.2 for Safety, medical device manufacturers and other embedded system suppliers are empowered with ultimate design flexibility and scalability to consolidate multiple systems with mixed criticality and different operating environments onto a single hardware platform, reducing both the initial development and long-term costs of ownership for a wide variety of embedded systems in industries such as industrial, automotive, transportation, heavy machinery, rail and robotics and more.

Medical device companies globally trust BlackBerry QNX software for a broad range of life-critical and graphics-rich medical applications including surgical robots, infusion pumps and pacemakers. BlackBerry QNX has a broad portfolio of embedded system software designed for mission-critical implementations, including the QNX® Hypervisor and the QNX® Neutrino® Real-time Operating System, in addition to middleware and development tools. Safety-certified variants of the QNX® OS for Safety are also available.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version